153 related articles for article (PubMed ID: 24699252)
1. Involvement of the TP receptor in TNF-α-induced endothelial tissue factor expression.
Del Turco S; Basta G; Lazzerini G; Chancharme L; Lerond L; De Caterina R
Vascul Pharmacol; 2014 Aug; 62(2):49-56. PubMed ID: 24699252
[TBL] [Abstract][Full Text] [Related]
2. In vitro pharmacological evaluation of multitarget agents for thromboxane prostanoid receptor antagonism and COX-2 inhibition.
Hoxha M; Buccellati C; Capra V; Garella D; Cena C; Rolando B; Fruttero R; Carnevali S; Sala A; Rovati GE; Bertinaria M
Pharmacol Res; 2016 Jan; 103():132-43. PubMed ID: 26621246
[TBL] [Abstract][Full Text] [Related]
3. The thromboxane receptor antagonist S18886 but not aspirin inhibits atherogenesis in apo E-deficient mice: evidence that eicosanoids other than thromboxane contribute to atherosclerosis.
Cayatte AJ; Du Y; Oliver-Krasinski J; Lavielle G; Verbeuren TJ; Cohen RA
Arterioscler Thromb Vasc Biol; 2000 Jul; 20(7):1724-8. PubMed ID: 10894809
[TBL] [Abstract][Full Text] [Related]
4. Thromboxane prostanoid receptor activation impairs endothelial nitric oxide-dependent vasorelaxations: the role of Rho kinase.
Liu CQ; Leung FP; Wong SL; Wong WT; Lau CW; Lu L; Yao X; Yao T; Huang Y
Biochem Pharmacol; 2009 Aug; 78(4):374-81. PubMed ID: 19409373
[TBL] [Abstract][Full Text] [Related]
5. Effects of the dual TP receptor antagonist and thromboxane synthase inhibitor EV-077 on human endothelial and vascular smooth muscle cells.
Petri MH; Tellier C; Michiels C; Ellertsen I; Dogné JM; Bäck M
Biochem Biophys Res Commun; 2013 Nov; 441(2):393-8. PubMed ID: 24161392
[TBL] [Abstract][Full Text] [Related]
6. Enhanced airway smooth muscle cell thromboxane receptor signaling via activation of JNK MAPK and extracellular calcium influx.
Lei Y; Cao Y; Zhang Y; Edvinsson L; Xu CB
Eur J Pharmacol; 2011 Jan; 650(2-3):629-38. PubMed ID: 21036122
[TBL] [Abstract][Full Text] [Related]
7. Thromboxane A(2) receptor mediated activation of the mitogen activated protein kinase cascades in human uterine smooth muscle cells.
Miggin SM; Kinsella BT
Biochim Biophys Acta; 2001 May; 1539(1-2):147-62. PubMed ID: 11389977
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the human prostanoid TPalpha and TPbeta receptor isoforms mediated through activation of the EP(1) and IP receptors.
Walsh MT; Kinsella BT
Br J Pharmacol; 2000 Oct; 131(3):601-9. PubMed ID: 11015313
[TBL] [Abstract][Full Text] [Related]
9. Laminin receptor activation inhibits endothelial tissue factor expression.
Holy EW; Stämpfli SF; Akhmedov A; Holm N; Camici GG; Lüscher TF; Tanner FC
J Mol Cell Cardiol; 2010 Jun; 48(6):1138-45. PubMed ID: 19712679
[TBL] [Abstract][Full Text] [Related]
10. The human thromboxane A2 receptor alpha isoform (TP alpha) functionally couples to the G proteins Gq and G11 in vivo and is activated by the isoprostane 8-epi prostaglandin F2 alpha.
Kinsella BT; O'Mahony DJ; Fitzgerald GA
J Pharmacol Exp Ther; 1997 May; 281(2):957-64. PubMed ID: 9152406
[TBL] [Abstract][Full Text] [Related]
11. The isoprostane 8-iso-PGF2alpha suppresses monocyte adhesion to human microvascular endothelial cells via two independent mechanisms.
Kumar A; Kingdon E; Norman J
FASEB J; 2005 Mar; 19(3):443-5. PubMed ID: 15640282
[TBL] [Abstract][Full Text] [Related]
12. Characterization of endothelial thromboxane receptors in rabbit aorta.
Pfister SL
Prostaglandins Other Lipid Mediat; 2008 Dec; 87(1-4):54-61. PubMed ID: 18812232
[TBL] [Abstract][Full Text] [Related]
13. Liver kinase B1 is required for thromboxane receptor-dependent nuclear factor-κB activation and inflammatory responses.
He J; Zhou Y; Xing J; Wang Q; Zhu H; Zhu Y; Zou MH
Arterioscler Thromb Vasc Biol; 2013 Jun; 33(6):1297-305. PubMed ID: 23539217
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
Meja KK; Barnes PJ; Giembycz MA
Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541
[TBL] [Abstract][Full Text] [Related]
15. Thromboxane A2 Receptor Inhibition Suppresses Multiple Myeloma Cell Proliferation by Inducing p38/c-Jun N-terminal Kinase (JNK) Mitogen-activated Protein Kinase (MAPK)-mediated G2/M Progression Delay and Cell Apoptosis.
Liu Q; Tao B; Liu G; Chen G; Zhu Q; Yu Y; Yu Y; Xiong H
J Biol Chem; 2016 Feb; 291(9):4779-92. PubMed ID: 26724804
[TBL] [Abstract][Full Text] [Related]
16. Diversity and similarity in signaling events leading to rapid Cox-2 induction by tumor necrosis factor-alpha and phorbol ester in human endothelial cells.
Eligini S; Barbieri SS; Cavalca V; Camera M; Brambilla M; De Franceschi M; Tremoli E; Colli S
Cardiovasc Res; 2005 Feb; 65(3):683-93. PubMed ID: 15664395
[TBL] [Abstract][Full Text] [Related]
17. Involvement of cyclo-oxygenase-1-mediated prostacyclin synthesis in the vasoconstrictor activity evoked by ACh in mouse arteries.
Liu B; Luo W; Zhang Y; Li H; Zhu N; Huang D; Zhou Y
Exp Physiol; 2012 Feb; 97(2):277-89. PubMed ID: 22080487
[TBL] [Abstract][Full Text] [Related]
18. S18886, a selective TP receptor antagonist, inhibits development of atherosclerosis in rabbits.
Worth NF; Berry CL; Thomas AC; Campbell JH
Atherosclerosis; 2005 Nov; 183(1):65-73. PubMed ID: 15950232
[TBL] [Abstract][Full Text] [Related]
19. Thromboxane A2 receptor blockade suppresses intercellular adhesion molecule-1 expression by stimulated vascular endothelial cells.
Ishizuka T; Suzuki K; Kawakami M; Hidaka T; Matsuki Y; Nakamura H
Eur J Pharmacol; 1996 Oct; 312(3):367-77. PubMed ID: 8894620
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of adrenaline vasoconstrictor response by sub-threshold concentrations of U-46619 in human umbilical vein: involvement of smooth muscle prostanoid TP(alpha) receptor isoform.
Errasti AE; Luciani LI; Cesio CE; Tramontano J; Boveris D; Daray FM; Nowak W; Pelorosso FG; Rothlin RP
Eur J Pharmacol; 2007 May; 562(3):227-35. PubMed ID: 17362923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
